Compare SFIX & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFIX | CMPX |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.6M | 408.8M |
| IPO Year | 2017 | 2020 |
| Metric | SFIX | CMPX |
|---|---|---|
| Price | $3.61 | $2.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $4.50 | ★ $14.57 |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 06-09-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.44 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,226,505,000.00 | N/A |
| Revenue This Year | $8.04 | N/A |
| Revenue Next Year | $3.73 | $934.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.52 | N/A |
| 52 Week Low | $2.95 | $1.61 |
| 52 Week High | $5.92 | $6.88 |
| Indicator | SFIX | CMPX |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 44.68 |
| Support Level | $3.43 | $1.88 |
| Resistance Level | $3.78 | $2.14 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 38.94 | 25.68 |
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.